Reduction Rate of Specific IgE Level As a Predictor of Persistent Egg Allergy in Children
Overview
Authors
Affiliations
Purpose: Egg is the most common food allergen in infants. However, the natural course of egg allergy has not been fully elucidated. This study aimed to describe clinical characteristics and to identify prognostic factors associated with tolerance acquisition of immunoglobulin E (IgE)-mediated egg allergy in children.
Methods: Children who underwent more than 1 follow-up egg white-specific immunoglobulin E (EWsIgE) test between November 2005 and November 2015 at -Severance Children's Hospital were assessed. Children were diagnosed as having IgE-mediated egg allergy based on immediate allergic reaction after egg consumption and an EWsIgE level of > 0.35 kU/L. The children were divided into "tolerant" and "persistent" groups according to tolerance acquisition defined as egg consumption without adverse allergic reactions.
Results: Of 124 participants, egg allergy resolved in 101 (81.5%) children. The persistent group had more atopic dermatitis ( = 0.039), and more wheat ( = 0.009) and peanut ( = 0.012) allergies compared to the tolerant group. The EWsIgE levels at diagnosis (EWsIgE) were higher in the persistent group than in the tolerant group ( = 0.001). The trend of the EWsIgE levels in the tolerant group decreased markedly over time compared to the persistent group ( < 0.001). In predicting egg allergy tolerance acquisition, the reduction rate of EWsIgE level after 12 months from diagnosis (ΔEWsIgE) tended to be more accurate than EWsIgE (area under the curve: 0.835 0.731). When ΔEWsIgE was ≥ 30%, tolerance acquisition was more frequent than that of < 30% (91.9% 57.9%; < 0.001).
Conclusions: ΔEWsIgE can be used as an early independent predictor of tolerance acquisition of IgE-mediated egg allergy in children.
van der Rijst L, Hilbrands M, Zuithoff N, de Bruin-Weller M, Knulst A, Le T Clin Transl Allergy. 2024; 14(7):e12381.
PMID: 39019593 PMC: 11254451. DOI: 10.1002/clt2.12381.
Randhawa I, Marsteller N J Allergy Clin Immunol Glob. 2024; 3(3):100285.
PMID: 38983112 PMC: 11231699. DOI: 10.1016/j.jacig.2024.100285.
Predicting the Outcome of Pediatric Oral Food Challenges for Determining Tolerance Development.
Kim H, Jeong K, Park M, Roh Y, Jung J, Kim S Allergy Asthma Immunol Res. 2024; 16(2):179-190.
PMID: 38528385 PMC: 10973639. DOI: 10.4168/aair.2024.16.2.179.
IgE and IgG4 epitopes of the peanut allergens shift following oral immunotherapy.
Rambo I, Kronfel C, Rivers A, Swientoniewski L, McBride J, Cheng H Front Allergy. 2023; 4:1279290.
PMID: 38093814 PMC: 10717846. DOI: 10.3389/falgy.2023.1279290.
Taniuchi S, Sakai R, Nishida T, Goma M, Mitomori M, Imaide A Nutrients. 2023; 15(12).
PMID: 37375671 PMC: 10302081. DOI: 10.3390/nu15122770.